Buy or sell Enlitic stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Enlitic Stock
Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.
About Enlitic Stock
Enlitic Inc. is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis. With a platform developed by renowned data scientists, machine learning practitioners, and medical experts, Enlitic is able to analyze a wide variety of healthcare data sources, including billions of clinical cases, to improve diagnostic accuracy, speed and patient outcomes, as well as accelerate pharmaceutical research and drug trials. Named one of the world’s “50 Smartest Companies” by MIT Tech Review, Enlitic is based San Francisco and serves customers around the world.
Funding History
| October 2014 | $5.0M |
|---|---|
| October 2015 | $10.0M |
| April 2019 | $15.0M |
Management
Chief Executive Officer
Kevin Lyman
Head of Product, Marketing & Strategy
Vanessa Sawyer
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
